安培龙：2025年前三季度净利润约7313万元，同比增加17.2%

Group 1 - Company Anpeilong reported Q3 performance with revenue of approximately 862 million yuan, a year-on-year increase of 30.27% [1] - The net profit attributable to shareholders was approximately 73.13 million yuan, reflecting a year-on-year increase of 17.2% [1] - Basic earnings per share reached 0.7432 yuan, marking a year-on-year increase of 17.21% [1] Group 2 - As of the report, Anpeilong's market capitalization stands at 14.7 billion yuan [2] - The Chinese innovative drug sector has seen overseas licensing sales reach 80 billion USD this year [2] - There is a contrast in the biopharmaceutical secondary market's heat versus the cooling fundraising environment in the primary market [2]